{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:12:31Z","timestamp":1793517151062,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40533-3","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:34:57Z","timestamp":1771230897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dysregulation of Endothelial cell markers in polycystic ovary syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Preeti","family":"Borde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Anjum","family":"Niinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniya","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh Suzu-Nishio","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"40533_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. Lancet 370, 685\u2013697 (2007).","journal-title":"Lancet"},{"key":"40533_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","volume":"29","author":"KA Walters","year":"2018","unstructured":"Walters, K. A. et al. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol. Metab. 29, 841\u2013852. https:\/\/doi.org\/10.1016\/j.tem.2018.08.005 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"40533_CR3","doi-asserted-by":"publisher","unstructured":"Christ, J. P. & Cedars, M. I. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 13. https:\/\/doi.org\/10.3390\/diagnostics13061113 (2023).","DOI":"10.3390\/diagnostics13061113"},{"key":"40533_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","volume":"50","author":"S Chang","year":"2021","unstructured":"Chang, S. & Dunaif, A. Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When? Endocrinol. Metab. Clin. North. Am. 50, 11\u201323. https:\/\/doi.org\/10.1016\/j.ecl.2020.10.002 (2021).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"40533_CR5","unstructured":"Organization, W. H. Polycystic ovary syndrome, (2025)."},{"key":"40533_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jri.2011.09.003","volume":"92","author":"ME Solano","year":"2011","unstructured":"Solano, M. E., Sander, V. A., Ho, H., Motta, A. B. & Arck, P. C. Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS). J. Reprod. Immunol. 92, 33\u201344 (2011).","journal-title":"J. Reprod. Immunol."},{"key":"40533_CR7","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1093\/ejendo\/lvad083","volume":"189","author":"MM Ollila","year":"2023","unstructured":"Ollila, M. M., Hoek, A. & Piltonen, T. T. The association between polycystic ovary syndrome and early cardiovascular disease morbidity strengthens. Eur. J. Endocrinol. 189, R4\u2013R5. https:\/\/doi.org\/10.1093\/ejendo\/lvad083 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"40533_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1530\/EJE-11-0755","volume":"166","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan, T. & Atkin, S. Mechanisms in endocrinology: recent advances in cardiovascular aspects of polycystic ovary syndrome. Eur. J. Endocrinol. 166, 575\u2013583 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"40533_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","volume":"117","author":"C Guan","year":"2022","unstructured":"Guan, C. et al. Polycystic ovary syndrome: a risk-enhancing factor for cardiovascular disease. Fertil. Steril. 117, 924\u2013935 (2022).","journal-title":"Fertil. Steril."},{"key":"40533_CR10","doi-asserted-by":"publisher","first-page":"552421","DOI":"10.3389\/fcvm.2020.552421","volume":"7","author":"J Zhang","year":"2020","unstructured":"Zhang, J., Xu, J. H., Qu, Q. Q. & Zhong, G. Q. Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies. Front. Cardiovasc. Med. 7, 552421 (2020).","journal-title":"Front. Cardiovasc. Med."},{"key":"40533_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker, V. et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum. Reprod. Update. 26, 942\u2013960 (2020).","journal-title":"Hum. Reprod. Update"},{"key":"40533_CR12","doi-asserted-by":"publisher","first-page":"33715","DOI":"10.18632\/oncotarget.9553","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget 7, 33715 (2016).","journal-title":"Oncotarget"},{"key":"40533_CR13","first-page":"74","volume":"70","author":"S Iftikhar","year":"2012","unstructured":"Iftikhar, S. et al. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth. J. Med. 70, 74 (2012).","journal-title":"Neth. J. Med."},{"key":"40533_CR14","doi-asserted-by":"crossref","unstructured":"Tay, C. T. et al. 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta\u2010Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome.\u00a0J. Am. Heart Assoc.\u00a013, e033572 (2024).","DOI":"10.1161\/JAHA.123.033572"},{"key":"40533_CR15","first-page":"1560","volume":"31","author":"Z Wan","year":"2024","unstructured":"Wan, Z. et al. Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome. Eur. J. Prev. Cardiol. 31, 1560\u20131570 (2024).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"40533_CR16","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena, H., Chiovato, L. & Nappi, R. E. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J. Clin. Endocrinol. Metabolism. 105, e2695\u2013e2709 (2020).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"40533_CR17","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.1210\/jc.2005-1002","volume":"90","author":"JJ Puder","year":"2005","unstructured":"Puder, J. J. et al. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J. Clin. Endocrinol. Metabolism. 90, 6014\u20136021 (2005).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"40533_CR18","first-page":"117955811987404","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber, T. M., Hanson, P., Weickert, M. O. & Franks, S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin. Med. Insights: Reproductive Health. 13, 1179558119874042 (2019).","journal-title":"Clin. Med. Insights: Reproductive Health"},{"key":"40533_CR19","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1038\/s41598-020-61531-z","volume":"10","author":"H Kahal","year":"2020","unstructured":"Kahal, H. et al. Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects. Sci. Rep. 10, 4750 (2020).","journal-title":"Sci. Rep."},{"key":"40533_CR20","doi-asserted-by":"crossref","unstructured":"Butler, A. E., Moin, A. S. M., Sathyapalan, T. & Atkin, S. L. Complement dysregulation in obese versus nonobese polycystic ovary syndrome patients. Cells 12, 2022 (2023).","DOI":"10.3390\/cells12152002"},{"key":"40533_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/cen.14904","volume":"98","author":"ASM Moin","year":"2023","unstructured":"Moin, A. S. M., Sathyapalan, T., Butler, A. E. & Atkin, S. L. Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity. Clin. Endocrinol. 98, 796\u2013802 (2023).","journal-title":"Clin. Endocrinol."},{"key":"40533_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12192-019-01048-1","volume":"25","author":"RV Vince","year":"2020","unstructured":"Vince, R. V., Kirk, R. J., Aye, M. M., Atkin, S. L. & Madden, L. A. Impaired heat shock protein 72 expression in women with polycystic ovary syndrome following a supervised exercise programme. Cell. Stress Chaperones. 25, 73\u201380 (2020).","journal-title":"Cell. Stress Chaperones"},{"key":"40533_CR23","first-page":"100084","volume":"7","author":"A Ray","year":"2023","unstructured":"Ray, A., Maharana, K. C., Meenakshi, S. & Singh, S. Endothelial dysfunction and its relation in different disorders: Recent update. Health Sci. Rev. 7, 100084 (2023).","journal-title":"Health Sci. Rev."},{"key":"40533_CR24","doi-asserted-by":"publisher","first-page":"101861","DOI":"10.1016\/j.redox.2021.101861","volume":"40","author":"P Guerby","year":"2021","unstructured":"Guerby, P. et al. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 40, 101861 (2021).","journal-title":"Redox Biol."},{"key":"40533_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/0929867326666190830103219","volume":"27","author":"E Oikonomou","year":"2020","unstructured":"Oikonomou, E. et al. Coronary artery disease and endothelial dysfunction: novel diagnostic and therapeutic approaches. Curr. Med. Chem. 27, 1052\u20131080 (2020).","journal-title":"Curr. Med. Chem."},{"key":"40533_CR26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/biomedicines10071745","volume":"10","author":"M Kajikawa","year":"2022","unstructured":"Kajikawa, M. & Higashi, Y. Obesity and endothelial function. Biomedicines 10, 1745 (2022).","journal-title":"Biomedicines"},{"key":"40533_CR27","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina, E. & Ley, K. Vascular Adhesion Molecules in Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2292\u20132301. https:\/\/doi.org\/10.1161\/ATVBAHA.107.149179 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"40533_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen, P., Eklund, L. & Alitalo, K. Therapeutic targeting of the angiopoietin\u2013TIE pathway. Nat. Rev. Drug Discovery. 16, 635\u2013661. https:\/\/doi.org\/10.1038\/nrd.2016.278 (2017).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"40533_CR29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2015.02.040","volume":"65","author":"ON Okafor","year":"2015","unstructured":"Okafor, O. N. & Gorog, D. A. Endogenous fibrinolysis: an important mediator of thrombus formation and cardiovascular risk. J. Am. Coll. Cardiol. 65, 1683\u20131699 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"40533_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","volume":"115","author":"JE Deanfield","year":"2007","unstructured":"Deanfield, J. E., Halcox, J. P. & Rabelink, T. J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285\u20131295 (2007).","journal-title":"Circulation"},{"key":"40533_CR31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","volume":"108","author":"PE Szmitko","year":"2003","unstructured":"Szmitko, P. E. et al. New markers of inflammation and endothelial cell activation: Part I. Circulation 108, 1917\u20131923 (2003).","journal-title":"Circulation"},{"key":"40533_CR32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1471-0528.2006.01090.x","volume":"113","author":"GD Brinkworth","year":"2006","unstructured":"Brinkworth, G. D., Noakes, M., Moran, L. J., Norman, R. & Clifton, P. M. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. BJOG: Int. J. Obstet. Gynecol. 113, 1308\u20131314 (2006).","journal-title":"BJOG: Int. J. Obstet. Gynecol."},{"key":"40533_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1210\/jc.2002-020386","volume":"88","author":"G Paradisi","year":"2003","unstructured":"Paradisi, G., Steinberg, H. O., Shepard, M. K., Hook, G. & Baron, A. D. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metabolism. 88, 576\u2013580 (2003).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"40533_CR34","first-page":"1851","volume":"85","author":"KJ Mather","year":"2000","unstructured":"Mather, K. J., Verma, S., Corenblum, B. & Anderson, T. J. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metabolism. 85, 1851\u20131856 (2000).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"40533_CR35","first-page":"3","volume":"32","author":"M Burl\u00e1","year":"2019","unstructured":"Burl\u00e1, M. et al. Endothelial dysfunction and pulse wave reflection in women with polycystic ovarian syndrome. Int. J. Cardiovasc. Sci. 32, 3\u20139 (2019).","journal-title":"Int. J. Cardiovasc. Sci."},{"key":"40533_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejogrb.2010.10.027","volume":"155","author":"N Raja-Khan","year":"2011","unstructured":"Raja-Khan, N. et al. Brachial artery conductance during reactive hyperemia is increased in women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reproductive Biology. 155, 49\u201353 (2011).","journal-title":"Eur. J. Obstet. Gynecol. Reproductive Biology"},{"key":"40533_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fendo.2019.00189","volume":"10","author":"AJ Dawson","year":"2019","unstructured":"Dawson, A. J. et al. The effect of exenatide on cardiovascular risk markers in women with polycystic ovary syndrome. Front. Endocrinol. 10, 189 (2019).","journal-title":"Front. Endocrinol."},{"key":"40533_CR38","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh, V., Kaur, R., Kumari, P., Pasricha, C. & Singh, R. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. Clin. Chim. Acta. 548, 117487 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"40533_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/biology12050743","volume":"12","author":"CD Haydinger","year":"2023","unstructured":"Haydinger, C. D., Ashander, L. M., Tan, A. C. R. & Smith, J. R. Intercellular adhesion molecule 1: more than a leukocyte adhesion molecule. Biology 12, 743 (2023).","journal-title":"Biology"},{"key":"40533_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-019-0566-5","volume":"12","author":"NM Rashad","year":"2019","unstructured":"Rashad, N. M. et al. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome. J. ovarian Res. 12, 1\u201312 (2019).","journal-title":"J. ovarian Res."},{"key":"40533_CR41","unstructured":"Jilani, T. N. & Siddiqui, A. H. in StatPearls [Internet] (StatPearls Publishing, 2023)."},{"key":"40533_CR42","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.3390\/ijms21197066","volume":"21","author":"FA Rahman","year":"2020","unstructured":"Rahman, F. A. & Krause, M. P. PAI-1, the plasminogen system, and skeletal muscle. Int. J. Mol. Sci. 21, 7066 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"40533_CR43","unstructured":"Bounds, E. J. & Kok, S. (2017). J. D dimer."},{"key":"40533_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3109\/09513590.2010.487592","volume":"26","author":"\u00c5 Lindholm","year":"2010","unstructured":"Lindholm, \u00c5. et al. Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome. Gynecol. Endocrinol. 26, 743\u2013748 (2010).","journal-title":"Gynecol. Endocrinol."},{"key":"40533_CR45","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1038\/s41598-021-84586-y","volume":"11","author":"ASM Moin","year":"2021","unstructured":"Moin, A. S. M. et al. Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome. Sci. Rep. 11, 5320 (2021).","journal-title":"Sci. Rep."},{"key":"40533_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","volume":"69","author":"WU Atiomo","year":"1998","unstructured":"Atiomo, W. U. et al. The plasminogen activator system in women with polycystic ovary syndrome. Fertil. Steril. 69, 236\u2013241 (1998).","journal-title":"Fertil. Steril."},{"key":"40533_CR47","doi-asserted-by":"crossref","unstructured":"Atiomo, W. U. et al. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Clinical endocrinology. 52, (2000).","DOI":"10.1046\/j.1365-2265.2000.00946.x"},{"key":"40533_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","volume":"78","author":"VS Sprung","year":"2013","unstructured":"Sprung, V. S. et al. Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta\u2010analysis of the observational studies. Clin. Endocrinol. 78, 438\u2013446 (2013).","journal-title":"Clin. Endocrinol."},{"key":"40533_CR49","doi-asserted-by":"publisher","first-page":"H522","DOI":"10.1152\/ajpheart.00745.2017","volume":"316","author":"KL Moreau","year":"2019","unstructured":"Moreau, K. L. Modulatory influence of sex hormones on vascular aging. Am. J. Physiol. Heart Circ. Physiol. 316, H522\u2013H526 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"40533_CR50","doi-asserted-by":"publisher","first-page":"E818","DOI":"10.1152\/ajpendo.00343.2013","volume":"305","author":"MM Wenner","year":"2013","unstructured":"Wenner, M. M., Taylor, H. S. & Stachenfeld, N. S. Androgens influence microvascular dilation in PCOS through ET-A and ET-B receptors. Am. J. Physiology-Endocrinology Metabolism. 305, E818\u2013E825 (2013).","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"40533_CR51","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1113\/JP277756","volume":"597","author":"CW Usselman","year":"2019","unstructured":"Usselman, C. W. et al. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. J. Physiol. 597, 2853\u20132865 (2019).","journal-title":"J. Physiol."},{"key":"40533_CR52","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4103\/2230-8210.103011","volume":"16","author":"P Saxena","year":"2012","unstructured":"Saxena, P., Prakash, A., Nigam, A. & Mishra, A. Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J. Endocrinol. Metabol. 16, 996\u2013999 (2012).","journal-title":"Indian J. Endocrinol. Metabol."},{"key":"40533_CR53","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1093\/humrep\/der296","volume":"26","author":"IJG Ketel","year":"2011","unstructured":"Ketel, I. J. G. et al. Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS. Hum. Reprod. 26, 3130\u20133137. https:\/\/doi.org\/10.1093\/humrep\/der296 (2011).","journal-title":"Hum. Reprod."},{"key":"40533_CR54","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1210\/jc.2004-0751","volume":"89","author":"I Tarkun","year":"2004","unstructured":"Tarkun, I. et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J. Clin. Endocrinol. Metabolism. 89, 5592\u20135596 (2004).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"40533_CR55","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1503\/cmaj.120677","volume":"185","author":"ST Bird","year":"2013","unstructured":"Bird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M. & Delaney, J. A. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. Cmaj 185, E115\u2013E120 (2013).","journal-title":"Cmaj"},{"key":"40533_CR56","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","volume":"1","author":"I Juhan-Vague","year":"2003","unstructured":"Juhan-Vague, I., Alessi, M. C., Mavri, A. & Morange, P. E. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J. Thromb. Haemost. 1, 1575\u20131579. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00279.x (2003).","journal-title":"J. Thromb. Haemost."},{"key":"40533_CR57","doi-asserted-by":"publisher","first-page":"100376","DOI":"10.1016\/j.jcte.2024.100376","volume":"38","author":"SL Atkin","year":"2024","unstructured":"Atkin, S. L., Butler, A. E., Jamialahmadi, T. & Sahebkar, A. PCSK7 levels in women with and without PCOS. J. Clin. Translational Endocrinol. 38, 100376 (2024).","journal-title":"J. Clin. Translational Endocrinol."},{"key":"40533_CR58","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba, S. et al. Pregnancy complications in women with polycystic ovary syndrome. Hum. Reprod. Update. 21, 575\u2013592 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"40533_CR59","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry, J. A., Azizia, M. M. & Hardiman, P. J. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update. 20, 748\u2013758 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"40533_CR60","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","volume":"12","author":"A Satyaraddi","year":"2019","unstructured":"Satyaraddi, A. et al. Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome. J. Hum. Reprod. Sci. 12, 78\u201384. https:\/\/doi.org\/10.4103\/jhrs.JHRS_2_19 (2019).","journal-title":"J. Hum. Reprod. Sci."},{"key":"40533_CR61","doi-asserted-by":"publisher","unstructured":"Polak, A. M. et al. Body Composition, Serum Concentrations of Androgens and Insulin Resistance in Different Polycystic Ovary Syndrome Phenotypes. J. Clin. Med. 9 https:\/\/doi.org\/10.3390\/jcm9030732 (2020).","DOI":"10.3390\/jcm9030732"},{"key":"40533_CR62","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cen.13517","volume":"88","author":"T Sathyapalan","year":"2018","unstructured":"Sathyapalan, T., Al-Qaissi, A., Kilpatrick, E. S., Dargham, S. R. & Atkin, S. L. Anti\u2010M\u00fcllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Clin. Endocrinol. 88, 258\u2013262 (2018).","journal-title":"Clin. Endocrinol."},{"key":"40533_CR63","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1038\/s41598-017-03945-w","volume":"7","author":"T Sathyapalan","year":"2017","unstructured":"Sathyapalan, T. et al. Salivary testosterone measurement in women with and without polycystic ovary syndrome. Sci. Rep. 7, 3589 (2017).","journal-title":"Sci. Rep."},{"key":"40533_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fendo.2019.00013","volume":"10","author":"TK Cunningham","year":"2019","unstructured":"Cunningham, T. K. et al. Association of vitamin D metabolites with embryo development and fertilization in women with and without PCOS undergoing subfertility treatment. Front. Endocrinol. 10, 13 (2019).","journal-title":"Front. Endocrinol."},{"key":"40533_CR65","doi-asserted-by":"publisher","first-page":"12232","DOI":"10.3390\/ijms232012232","volume":"23","author":"AE Butler","year":"2022","unstructured":"Butler, A. E., Moin, A. S. M., Sathyapalan, T. & Atkin, S. L. Components of the complement cascade differ in polycystic ovary syndrome. Int. J. Mol. Sci. 23, 12232 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"40533_CR66","doi-asserted-by":"publisher","first-page":"e26332","DOI":"10.1371\/journal.pone.0026332","volume":"6","author":"S Kraemer","year":"2011","unstructured":"Kraemer, S. et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PloS one. 6, e26332 (2011).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40533-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:04:50Z","timestamp":1773831890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40533-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9300"}}